Physician and economist Jay Bhattacharya has been selected by Donald Trump to lead the National Institutes of Health.

Nonmainstream doctors and health leaders are wielding serious muscle in shaping the incoming administration’s health policies ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

Under a new rule the Biden administration proposed on Tuesday, millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or ...

Federal officials announced Tuesday that audits they launched earlier this year have led to significant new reforms.

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...

The Biden administration is proposing a new rule to significantly expand the coverage of weight-loss drugs for Americans on ...

The Biden administration is proposing a rule that would require the US government to cover obesity drugs for millions of ...

The White House announced Tuesday that Biden would propose a new rule to expand coverage of anti-obesity medications — such ...

The White House said it's moving to make the federal health insurance plans pay for anti-obesity drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound for people who are obese, even if they don ...